Literature DB >> 10190221

Schizoaffective disorder: role of atypical antipsychotics.

P E Keck1, S L McElroy, S M Strakowski.   

Abstract

The pharmacologic treatment of schizoaffective disorder is one of the least well-studied areas of contemporary pharmacotherapy. The authors review available literature on the traditional pharmacologic treatment of schizoaffective disorder, new data on the atypical antipsychotics, and potential pharmacologic mechanisms by which these new agents may produce thymoleptic activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10190221     DOI: 10.1016/s0920-9964(98)00165-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

1.  Role of paliperidone extended-release in treatment of schizoaffective disorder.

Authors:  Carla M Canuso; Ibrahim Turkoz; Dong Jing Fu; Cynthia A Bossie
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

2.  The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis.

Authors:  Ibrahim Turkoz; Dong-Jing Fu; Cynthia A Bossie; Larry Alphs
Journal:  Innov Clin Neurosci       Date:  2015 Nov-Dec

Review 3.  A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder.

Authors:  Pierre Chue; James Chue
Journal:  Ther Clin Risk Manag       Date:  2016-01-27       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.